BiotechTube

Clotrimazole vaginal tablet + Fluconazole

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Candidiasis, Vulvovaginal

Conditions

Candidiasis, Vulvovaginal

Trial Timeline

Jul 1, 2014 → Sep 1, 2015

NCT ID
NCT02180828

About Clotrimazole vaginal tablet + Fluconazole

Clotrimazole vaginal tablet + Fluconazole is a approved stage product being developed by Bayer for Candidiasis, Vulvovaginal. The current trial status is completed. This product is registered under clinical trial identifier NCT02180828. Target conditions include Candidiasis, Vulvovaginal.

What happened to similar drugs?

4 of 20 similar drugs in Candidiasis, Vulvovaginal were approved

Approved (4) Terminated (4) Active (13)
✅Fluconazole + MicafunginAstellas PharmaApproved
✅Caspofungin + Normal SalineMerckApproved
✅VoriconazolePfizerApproved
✅Eraxis (anidulafungin) + Diflucan (fluconazole) + Vfend (voriconazole)PfizerApproved
🔄Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
🔄Micafungin + fluconazoleAstellas PharmaPhase 3
🔄Micafungin + CaspofunginAstellas PharmaPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02180828ApprovedCompleted

Competing Products

20 competing products in Candidiasis, Vulvovaginal

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaPhase 1
29
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
40
Micafungin + fluconazoleAstellas PharmaPhase 3
40
Micafungin (Mycamine)Astellas PharmaPhase 1
29
Fluconazole + MicafunginAstellas PharmaApproved
35
Micafungin + CaspofunginAstellas PharmaPhase 3
40
Micafungin + FluconazoleAstellas PharmaPhase 3
40
MicafunginAstellas PharmaPhase 2
35
micafungin + caspofunginAstellas PharmaPhase 3
40
micafungin + amphotericin B deoxycholateAstellas PharmaPhase 3
32
FK463Astellas PharmaPhase 2
35
Micafungin + Liposomal Amphotericin BAstellas PharmaPhase 3
40
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
36
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
36
L-743,872MerckPre-clinical
26
CaspofunginMerckPhase 2
35
L-743,872MerckPhase 2
27
Caspofungin + Amphotericin B DeoxycholateMerckPhase 2
27
Caspofungin acetate + PlaceboMerckPhase 2
27
Caspofungin + Normal SalineMerckApproved
43